Michael Romanko - 04 Mar 2025 Form 4 Insider Report for Petco Health & Wellness Company, Inc. (WOOF)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
06 Mar 2025, 18:52:44 UTC
Prior SEC filing
04 Mar 2025
Next SEC filing
19 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Giovanni Insana, as Attorney-in-Fact

Key filing fact

Michael Romanko filed Form 4 for Petco Health & Wellness Company, Inc. (WOOF) on 06 Mar 2025.

Key facts

  • This page summarizes Michael Romanko's Form 4 filing for Petco Health & Wellness Company, Inc. (WOOF).
  • 3 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 06 Mar 2025, 18:52.

Change

  • Previous filing in this sequence was filed on 04 Mar 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

WOOF transaction

Class A Common Stock

Award

Transaction value
$0
Shares
+1,321,139
Change %
Price
$0.000000
Shares after
1,321,139
Date
04 Mar 2025
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

WOOF transaction Derivative

Employee Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+393,082
Change %
Price
$0.000000
Shares after
393,082
Date
04 Mar 2025
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
393,082
Exercise price
$2.46
Footnotes
F2
WOOF transaction Derivative

Performance Stock Unit

Award

Transaction value
$0
Shares
+323,835
Change %
Price
$0.000000
Shares after
323,835
Date
04 Mar 2025
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
323,835
Exercise price
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents 1,321,139 restricted stock units ("RSUs") granted to the Reporting Person on March 4, 2025. Each RSU represents the right to receive one share of Class A common stock of the Issuer. The RSUs will vest as follows: (i) 34% on the first anniversary of 3/4/2025 (the "Grant Date"); (ii) 16.5% on the date that is 18 months following the Grant Date; (iii) 16.5% on the second anniversary of the Grant Date; (iv) 16.5% on the date that is 30 months following the Grant Date; and (v) 16.5% on the third anniversary of the Grant Date. The RSUs were granted outside of the Petco Health and Wellness Company, Inc. 2021 Equity Incentive Plan (as amended, the "2021 Plan") as a material inducement to the Reporting Person's acceptance of employment with the Issuer in accordance with NASDAQ Listing Rule 5635(c)(4).

Footnote F2

Represents options to purchase Class A Common Stock of the Issuer. The options will vest as follows: (i) 34% on the first anniversary of the Grant Date; (ii) 16.5% on the date that is 18 months following the Grant Date; (iii) 16.5% on the second anniversary of the Grant Date; (iv) 16.5% on the date that is 30 months following the Grant Date; and (v) 16.5% on the third anniversary of the Grant Date. The options were granted outside of the 2021 Plan as a material inducement to the Reporting Person's acceptance of employment with the Issuer in accordance with NASDAQ Listing Rule 5635(c)(4).

Footnote F3

Represents the target number of performance stock units ("PSUs") granted. The PSUs represent the right to receive shares of Class A common stock of the Issuer in an amount from 0% to 200% of the target number of PSUs granted. The actual number of PSUs earned will be determined following a performance period ending January 29, 2028, based on the Issuer's total shareholder return during the performance period and subject to continued employment through the vesting date. The PSUs were granted outside of the 2021 Plan as a material inducement to the Reporting Person's acceptance of employment with the Issuer in accordance with NASDAQ Listing Rule 5635(c)(4).

SEC remarks

Chief Customer and Product Officer

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .